weav, it still won't be one strip for all because of the differences between glucose oxidase methods and glucose dehydroginase methods. But good news, DECN has completed for the most part the glucose oxidase method strips and can add another declining Abbott line, and a Sinocare line. But the gold mine is in the glucose dehydroginase meters and that opens a whole new world.

But, but, but weav, its really all and only about share price, regime change, and putting Mr. Berman is jail and of course a message board poster in charge because all shareholders would be better off with a poster in charge of the company. Qualifications ... who cares.